Perspective: COVID-19, implications of nasal diseases and consequences for their management
- 1 July 2020
- journal article
- editorial
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 146 (1), 67-69
- https://doi.org/10.1016/j.jaci.2020.04.030
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system suggests mechanisms underlying COVID-19-associated anosmiaScience Advances, 2020
- Letter: Precautions for Endoscopic Transnasal Skull Base Surgery During the COVID-19 PandemicNeurosurgery, 2020
- Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, ChinaAllergy, 2020
- SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across TissuesCell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statementAllergy, 2020
- SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected PatientsThe New England Journal of Medicine, 2020
- Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma modelToxicology and Applied Pharmacology, 2016
- Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In VitroPLOS ONE, 2009